2023-2024 BASIC AND CLINICAL SCIENCE COURSE™, SECTION 9: UVEITIS AND OCULAR INFLAMMATION

2023-2024 BASIC AND CLINICAL SCIENCE COURSE™, SECTION 9: UVEITIS AND OCULAR INFLAMMATION

Editorial:
AMERICAN ACADEMY OF OPHTHALMOLOGY
Año de edición:
Materia
Oftalmología
ISBN:
978-1-68104-621-1
Páginas:
384
N. de edición:
1
Idioma:
Inglés
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

209,00 €

Despues:

198,55 €

Section 9 of the Academy's Basic and Clinical Science Course™ (BCSC®) begins with an overview of immune-mediated eye disease, summarizing basic immunologic concepts, ocular immune responses and special topics in ocular immunology.

BCSC Section 9 covers diagnostic considerations, therapies and complications for uveitis. This volume reviews noninfectious (autoimmune) and infectious forms of uveitis. A new table summarizes selected systemic immunomodulatory medications used to treat noninfectious uveitis. Additionally, a discussion on nonbacterial causes of infectious uveitis includes a new subsection on SARS-CoV-2 and COVID-19.

Other topics in Section 9 include scleritis, ocular involvement in HIV infection/AIDS, endophthalmitis and masquerade syndromes. The topic on posterior uveitis and panuveitis has been revised to two chapters to make the content more manageable. In addition, a second appendix about antimicrobial agents for intraocular injection is now included.

• New photos, Clinical Pearl boxes and other side bars appear throughout the book, presenting information that can be quickly applied to clinical practice. Increase your understanding with 7 videos and 1 interactive activity.
• Upon completion of Section 9, readers should be able to:
• Describe the immunologic and infectious mechanisms involved in the development of and complications from uveitis and related conditions, including AIDS
• Identify general and specific pathophysiologic processes in acute and chronic ocular inflammation that affect the structure and function of the uvea, lens, vitreous, retina, and other adjacent tissues
• Distinguish infectious from noninfectious uveitic entities
• State appropriate differential diagnoses for ocular inflammatory disorders and identify systemic associations or implications